Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Tumstatin, the non collagenous C-teminal domain of alpha-3(I...
| Class:Id | Summation:4085091 |
|---|---|
| _displayName | Tumstatin, the non collagenous C-teminal domain of alpha-3(I... |
| _timestamp | 2013-08-01 15:33:44 |
| created | [InstanceEdit:4085056] Jupe, S, 2013-08-01 |
| literatureReference | [LiteratureReference:4084751] Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins [LiteratureReference:4084767] Integrin alpha3beta1, a novel receptor for alpha3(IV) noncollagenous domain and a trans-dominant Inhibitor for integrin alphavbeta3 |
| text | Tumstatin, the non collagenous C-teminal domain of alpha-3(IV) collagen, binds to integrin alpha V beta 3 (Sudhakar et al. 2003) and alpha3beta1 (Borza et al. 2006). |
| (summation) | [Reaction:4085083] Tumstatin binds integrin alphaVbeta 3, alpha3beta1 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Tumstatin, the non collagenous C-teminal domain of alpha-3(I... (4085091)
